We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXDX
12976
PUT
DELISTED
Accelerate Diagnostics
AXDX
$30K ﹤0.01%
2,050
-1,530
-43% -$43.6K
BBLG
12977
Bone Biologics
BBLG
$1.69M
$30K ﹤0.01%
+7
New +$25.4K
BDSX icon
12978
Biodesix
BDSX
$248M
$30K ﹤0.01%
881
-1,585
-64% -$104K
CTMX icon
12979
PUT
CytomX Therapeutics
CTMX
$754M
$30K ﹤0.01%
11,400
-31,300
-73% -$120K
ENIC icon
12980
CALL
Enel Chile
ENIC
$6.28B
$30K ﹤0.01%
+19,200
New +$34.4K
FENG
12981
CALL
Phoenix New Media
FENG
$18M
$30K ﹤0.01%
8,800
+5,850
+198% +$25.3K
HGBL icon
12982
Heritage Global
HGBL
$36.8M
$30K ﹤0.01%
+21,934
New +$34.9K
PIIIW icon
12983
P3 Health Partners Inc Warrant
PIIIW
$179K
$30K ﹤0.01%
18,443
+1,375
+8% +$1.34K
SIEB icon
12984
PUT
Siebert Financial
SIEB
$68.4M
$30K ﹤0.01%
14,100
-12,200
-46% -$26.1K
SLE icon
12985
PUT
Super League Enterprise
SLE
$4.65M
$30K ﹤0.01%
2
WPRT
12986
CALL
Westport Fuel Systems
WPRT
$35.7M
$30K ﹤0.01%
+1,890
New +$33.8K
AMBR
12987
PUT
Amber International Holding Ltd
AMBR
$130M
$30K ﹤0.01%
2,550
-730
-22% -$20.9K
ENZ
12988
DELISTED
Enzo Biochem, Inc.
ENZ
$30K ﹤0.01%
10,502
-4,078
-28% -$13.1K
SYRS
12989
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$30K ﹤0.01%
2,560
+1,070
+72% +$19.1K
NVACW
12990
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$30K ﹤0.01%
+180,551
New +$32K
NBSE
12991
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$30K ﹤0.01%
+805
New +$27.8K
ELYS
12992
CALL
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$30K ﹤0.01%
12,800
-20,200
-61% -$54.2K
EPZM
12993
CALL
DELISTED
Epizyme, Inc
EPZM
$30K ﹤0.01%
26,100
+4,600
+21% +$7.5K
EPZM
12994
PUT
DELISTED
Epizyme, Inc
EPZM
$30K ﹤0.01%
26,100
-8,700
-25% -$14.2K
ABEO icon
12995
Abeona Therapeutics
ABEO
$413M
$29K ﹤0.01%
3,759
-9,549
-72% -$65.6K
BCDA icon
12996
CALL
BioCardia
BCDA
$14.6M
$29K ﹤0.01%
947
-4,166
-81% -$124K
JOB icon
12997
GEE Group
JOB
$22.5M
$29K ﹤0.01%
53,168
-25,765
-33% -$14.1K
PTPI
12998
CALL
DELISTED
Petros Pharmaceuticals
PTPI
$29K ﹤0.01%
74
+14
+23% +$5.9K
YARW
12999
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$29K ﹤0.01%
50
+14
+39% +$8.32K
ORKA
13000
PUT
Oruka Therapeutics
ORKA
$5.96B
$29K ﹤0.01%
1,033
-692
-40% -$17.1K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.